New Tecfidera® (Dimethyl Fumarate) data show stustained efficacy and long-term safety in a broad range of Multiple Sclerosis
Interim results from ENDORSE extension study reinforce favorable safety profile…
4 October 2013 | By Biogen Idec
Interim results from ENDORSE extension study reinforce favorable safety profile in patients treated for up to six and a half years...